U.S. flag

An official website of the United States government

Format

Send to:

Choose Destination

Scaling skin

MedGen UID:
472970
Concept ID:
C0237849
Finding
Synonyms: Desquamation; Scaling; Scaling of skin; Scaling of the skin; Skin scaling
SNOMED CT: Desquamation (14411002); Desquamative state (14411002); Scaling (14411002); Exfoliation (14411002); Desquamation, function (14411002); Peeling of skin (271767006); Exfoliating (271767006); Flaking of skin (271767006); Desquamation (271767006); Shedding of scales (271767006); Dropping of scales (271767006)
 
HPO: HP:0040189

Definition

Refers to the loss of the outer layer of the epidermis in large, scale-like flakes. [from HPO]

Conditions with this feature

MPDU1-congenital disorder of glycosylation
MedGen UID:
322968
Concept ID:
C1836669
Disease or Syndrome
Congenital disorders of glycosylation (CDGs) are metabolic deficiencies in glycoprotein biosynthesis that usually cause severe mental and psychomotor retardation. Different forms of CDGs can be recognized by altered isoelectric focusing (IEF) patterns of serum transferrin. For a general discussion of CDGs, see CDG Ia (212065) and CDG Ib (602579).
Ichthyosis hystrix of Curth-Macklin
MedGen UID:
326700
Concept ID:
C1840296
Disease or Syndrome
The Curth-Macklin type of ichthyosis hystrix (IHCM) is clinically characterized by severe fissuring and mutilating palmoplantar keratoderma. Affected individuals also exhibit extensive dark spiky or verrucous hyperkeratotic plaques over the large joints and trunk, which in some patients may cover almost the entire body. Structural and ultrastructural hallmarks include compact orthokeratotic hyperkeratosis, hypergranulosis with perinuclear edema, binucleated cells, and formation of perinuclear filamentous shells composed of feathery entangled keratin intermediate filaments (summary by Richardson et al., 2006 and Fonseca et al., 2013). The Lambert type of ichthyosis hystrix (IHL; 146600), in which palms and soles are spared, is caused by mutation in the KRT10 (148080) gene.
Annular epidermolytic ichthyosis
MedGen UID:
334410
Concept ID:
C1843463
Disease or Syndrome
A rare clinical variant of epidermolytic ichthyosis, with manifestations of blistering phenotype at birth and the development from early infancy of annular polycyclic erythematous scales on the trunk and extremities. It has been reported in less than 10 families. The disease is caused by mutations in the KRT1 (12q11-q13) and KRT10 (17q21-q23) genes, encoding keratins 1 and 10 respectively. These mutations impair keratin filament formation and weaken the structural stability of the keratinocyte cytoskeleton. Transmission is autosomal dominant.
Peeling skin syndrome 1
MedGen UID:
336530
Concept ID:
C1849193
Disease or Syndrome
A group of rare autosomal recessive forms of ichthyosis with clinical characteristics of superficial, asymptomatic, spontaneous peeling of the skin and histologically by a shedding of the outer layers of the epidermis. Presents with either an acral or a generalised distribution.
Acral peeling skin syndrome
MedGen UID:
342862
Concept ID:
C1853354
Disease or Syndrome
Epidermolysis bullosa simplex (EBS) is characterized by fragility of the skin (and mucosal epithelia in some instances) that results in non-scarring blisters and erosions caused by minor mechanical trauma. EBS is distinguished from other types of epidermolysis bullosa (EB) or non-EB skin fragility syndromes by the location of the blistering in relation to the dermal-epidermal junction. In EBS, blistering occurs within basal keratinocytes. The severity of blistering ranges from limited to hands and feet to widespread involvement. Additional features can include hyperkeratosis of the palms and soles (keratoderma), nail dystrophy, milia, and hyper- and/or hypopigmentation. Rare EBS subtypes have been associated with additional clinical features including pyloric atresia, muscular dystrophy, cardiomyopathy, and/or nephropathy.
Immunodeficiency due to CD25 deficiency
MedGen UID:
377894
Concept ID:
C1853392
Disease or Syndrome
Immunodeficiency-41 is an autosomal recessive complex disorder of immune dysregulation. Affected individuals present in infancy with recurrent viral, fungal, and bacterial infections, lymphadenopathy, and variable autoimmune features, such as autoimmune enteropathy and eczematous skin lesions. Immunologic studies show a defect in T-cell regulation (summary by Goudy et al., 2013).
Epidermolysis bullosa simplex due to plakophilin deficiency
MedGen UID:
388032
Concept ID:
C1858302
Disease or Syndrome
Ectodermal dysplasia/skin fragility syndrome (EDSFS) is an autosomal recessive genodermatosis characterized by widespread skin fragility, alopecia, nail dystrophy, and focal keratoderma with painful fissures. Hypohidrosis and cheilitis are sometimes present (summary by Ersoy-Evans et al., 2006).
Psoriasis 2
MedGen UID:
351141
Concept ID:
C1864497
Disease or Syndrome
Any psoriasis in which the cause of the disease is a mutation in the CARD14 gene.
Autosomal recessive congenital ichthyosis 6
MedGen UID:
436851
Concept ID:
C2677065
Disease or Syndrome
Autosomal recessive congenital ichthyosis (ARCI) encompasses several forms of nonsyndromic ichthyosis. Although most neonates with ARCI are collodion babies, the clinical presentation and severity of ARCI may vary significantly, ranging from harlequin ichthyosis, the most severe and often fatal form, to lamellar ichthyosis (LI) and (nonbullous) congenital ichthyosiform erythroderma (CIE). These phenotypes are now recognized to fall on a continuum; however, the phenotypic descriptions are clinically useful for clarification of prognosis and management. Infants with harlequin ichthyosis are usually born prematurely and are encased in thick, hard, armor-like plates of cornified skin that severely restrict movement. Life-threatening complications in the immediate postnatal period include respiratory distress, feeding problems, and systemic infection. Collodion babies are born with a taut, shiny, translucent or opaque membrane that encases the entire body and lasts for days to weeks. LI and CIE are seemingly distinct phenotypes: classic, severe LI with dark brown, plate-like scale with no erythroderma and CIE with finer whiter scale and underlying generalized redness of the skin. Affected individuals with severe involvement can have ectropion, eclabium, scarring alopecia involving the scalp and eyebrows, and palmar and plantar keratoderma. Besides these major forms of nonsyndromic ichthyosis, a few rare subtypes have been recognized, such as bathing suit ichthyosis, self-improving collodion ichthyosis, or ichthyosis-prematurity syndrome.
Aicardi-Goutieres syndrome 5
MedGen UID:
413116
Concept ID:
C2749659
Disease or Syndrome
Most characteristically, Aicardi-Goutières syndrome (AGS) manifests as an early-onset encephalopathy that usually, but not always, results in severe intellectual and physical disability. A subgroup of infants with AGS present at birth with abnormal neurologic findings, hepatosplenomegaly, elevated liver enzymes, and thrombocytopenia, a picture highly suggestive of congenital infection. Otherwise, most affected infants present at variable times after the first few weeks of life, frequently after a period of apparently normal development. Typically, they demonstrate the subacute onset of a severe encephalopathy characterized by extreme irritability, intermittent sterile pyrexias, loss of skills, and slowing of head growth. Over time, as many as 40% develop chilblain skin lesions on the fingers, toes, and ears. It is becoming apparent that atypical, sometimes milder, cases of AGS exist, and thus the true extent of the phenotype associated with pathogenic variants in the AGS-related genes is not yet known.
Congenital ichthyosis-intellectual disability-spastic quadriplegia syndrome
MedGen UID:
482486
Concept ID:
C3280856
Disease or Syndrome
ISQMR is a severe autosomal recessive disorder characterized by ichthyosis apparent from birth, profound psychomotor retardation with essentially no development, spastic quadriplegia, and seizures (summary by Aldahmesh et al., 2011).
Congenital reticular ichthyosiform erythroderma
MedGen UID:
777141
Concept ID:
C3665704
Disease or Syndrome
Ichthyosis with confetti (IWC), also known as congenital reticular ichthyosiform erythroderma (CRIE), is a rare skin condition characterized by slowly enlarging islands of normal skin surrounded by erythematous ichthyotic patches in a reticulated pattern. The condition starts in infancy as a lamellar ichthyosis, with small islands of normal skin resembling confetti appearing in late childhood and at puberty. Histopathologic findings include band-like parakeratosis, psoriasiform acanthosis, and vacuolization of keratinocytes with binucleated cells in the upper epidermis, sometimes associated with amyloid deposition in the dermis. Ultrastructural abnormalities include perinuclear shells formed from a network of fine filaments in the upper epidermis (summary by Krunic et al., 2003).
Peeling skin-leukonuchia-acral punctate keratoses-cheilitis-knuckle pads syndrome
MedGen UID:
902464
Concept ID:
C4225381
Disease or Syndrome
A rare genetic skin disease characterized by generalized skin peeling, leukonychia, acral punctate keratoses coalescing into focal keratoderma on the weight-bearing areas, angular cheilitis and knuckle pads with multiple hyperkeratotic micropapules. The skin appears dry and scaly with superficial exfoliation and underlying erythema. Histopathologic examination of affected skin areas shows hyperkeratosis, acanthosis and intraepidermal clefting with irregular acantholysis. Additional systemic abnormalities are absent.
Peeling skin syndrome 4
MedGen UID:
895692
Concept ID:
C4225407
Disease or Syndrome
Any peeling skin syndrome in which the cause of the disease is a mutation in the CSTA gene.
Peeling skin syndrome 5
MedGen UID:
934677
Concept ID:
C4310710
Disease or Syndrome
Peeling skin syndrome-5 (PSS5) is characterized by superficial peeling of the dorsal and palmar skin of the hands and feet; the skin of the forearms and legs may also be involved. Some patients exhibit diffuse yellowish hyperkeratotic palmoplantar plaques (Pigors et al., 2016). For a general phenotypic description and a discussion of genetic heterogeneity of peeling skin syndrome, see PSS1 (270300).
Ichthyosis, congenital, autosomal recessive 14
MedGen UID:
1620129
Concept ID:
C4539754
Congenital Abnormality
Amyloidosis, primary localized cutaneous, 1
MedGen UID:
1639046
Concept ID:
C4551501
Disease or Syndrome
In all forms of PLCA, the abnormal patches of skin usually arise in mid-adulthood. They can remain for months to years and may recur after disappearing, either at the same location or elsewhere. Very rarely, nodular amyloidosis progresses to a life-threatening condition called systemic amyloidosis, in which amyloid deposits accumulate in tissues and organs throughout the body.\n\nIn some affected individuals, the patches have characteristics of both lichen and macular amyloidosis. These cases are called biphasic amyloidosis.\n\nNodular amyloidosis is characterized by firm, raised bumps (nodules) that are pink, red, or brown. These nodules often occur on the face, torso, limbs, or genitals and are typically not itchy.\n\nIn macular amyloidosis, the patches are flat and dark brown. The coloring can have a lacy (reticulated) or rippled appearance, although it is often uniform. Macular amyloidosis patches are most commonly found on the upper back, but they can also occur on other parts of the torso or on the limbs. These patches are mildly itchy.\n\nLichen amyloidosis is characterized by severely itchy patches of thickened skin with multiple small bumps. The patches are scaly and reddish brown in color. These patches usually occur on the shins but can also occur on the forearms, other parts of the legs, and elsewhere on the body.\n\nPrimary localized cutaneous amyloidosis (PLCA) is a condition in which clumps of abnormal proteins called amyloids build up in the skin, specifically in the wave-like projections (dermal papillae) between the top two layers of skin (the dermis and the epidermis). The primary feature of PLCA is patches of skin with abnormal texture or color. The appearance of these patches defines three forms of the condition: lichen amyloidosis, macular amyloidosis, and nodular amyloidosis.
Peeling skin syndrome 6
MedGen UID:
1648406
Concept ID:
C4748093
Disease or Syndrome
Peeling skin syndrome-6 (PSS6) is characterized by generalized ichthyotic dry skin and bullous peeling lesions on the trunk and limbs at sites of minor trauma. There is residual hyperpigmentation in areas of healing, but no scarring. Skin symptoms are exacerbated by warmth and humidity; however, the disorder improves markedly with age (Bolling et al., 2018; Mohamad et al., 2018). For a discussion of genetic heterogeneity of peeling skin syndrome, see PSS1 (270300).
Severe combined immunodeficiency due to CARMIL2 deficiency
MedGen UID:
1648422
Concept ID:
C4748304
Disease or Syndrome
Immunodeficiency-58 is an autosomal recessive primary immunologic disorder characterized by early-onset skin lesions, including eczematous dermatitis, infectious abscesses, and warts, recurrent respiratory infections or allergies, and chronic persistent infections with candida, Molluscum contagiosum, mycobacteria, EBV, bacteria, and viruses. Some patients may have gastrointestinal involvement, including inflammatory bowel disease, EBV+ smooth muscle tumors, and esophagitis. Immunologic analysis shows defective T-cell function with decreased Treg cells and deficient CD3/CD28 costimulation responses in both CD4+ and CD8+ T cells. B-cell function may also be impaired (summary by Wang et al., 2016 and Alazami et al., 2018).
Cancer, alopecia, pigment dyscrasia, onychodystrophy, and keratoderma
MedGen UID:
1678330
Concept ID:
C5193062
Disease or Syndrome
CAPOK syndrome (CAPOK) is characterized by onset of symptoms in the first year of life, with the development of progressive alopecia, hypo- and hyperpigmented macular skin lesions, palmoplantar keratoderma, and nail dystrophy. Beginning in the third decade of life, patients develop recurrent squamous cell carcinomas. Some patients may have brittle teeth resulting in tooth loss, and multinodular goiter has been observed (Courcet et al., 2015).
Gonadal dysgenesis, dysmorphic facies, retinal dystrophy, and myopathy
MedGen UID:
1679397
Concept ID:
C5193085
Disease or Syndrome
Myoectodermal gonadal dysgenesis syndrome (MEGD) is characterized by 46,XY complete or partial gonadal dysgenesis, or 46,XX gonadal dysgenesis, in association with extragonadal anomalies, including low birth weight, typical facies, rod and cone dystrophy, sensorineural hearing loss, omphalocele, anal atresia, renal agenesis, skeletal abnormalities, dry and scaly skin, severe myopathy, and neuromotor delay. Dysmorphic facial features along with muscular habitus are the hallmarks of the syndrome. Abnormal hair patterning with frontal upsweep and additional whorls, eyebrow abnormalities comprising broad, arched, and sparse or thick eyebrows, underdeveloped alae nasi, smooth philtrum, and low-set ears with overfolded helices facilitate a gestalt diagnosis. (Guran et al., 2019; Altunoglu et al., 2022).
IFAP syndrome 1, with or without BRESHECK syndrome
MedGen UID:
1746744
Concept ID:
C5399971
Disease or Syndrome
The IFAP/BRESHECK syndrome is an X-linked multiple congenital anomaly disorder with variable severity. The classic triad, which defines IFAP, is ichthyosis follicularis, atrichia, and photophobia. Some patients have additional features, including mental retardation, brain anomalies, Hirschsprung disease, corneal opacifications, kidney dysplasia, cryptorchidism, cleft palate, and skeletal malformations, particularly of the vertebrae, which constitutes BRESHECK syndrome (summary by Naiki et al., 2012). Genetic Heterogeneity of IFAP Syndrome IFAP syndrome-2 (IFAP2; 619016) is caused by heterozygous mutation in the SREBF1 gene (184756) on chromosome 17p11.
Neurodevelopmental disorder with hypotonia and dysmorphic facies
MedGen UID:
1794184
Concept ID:
C5561974
Disease or Syndrome
Neurodevelopmental disorder with hypotonia and dysmorphic facies (NEDHYDF) is characterized by global developmental delay and hypotonia apparent from birth. Affected individuals have variably impaired intellectual development, often with speech delay and delayed walking. Seizures are generally not observed, although some patients may have single seizures or late-onset epilepsy. Most patients have prominent dysmorphic facial features. Additional features may include congenital cardiac defects (without arrhythmia), nonspecific renal anomalies, joint contractures or joint hyperextensibility, dry skin, and cryptorchidism. There is significant phenotypic variability in both the neurologic and extraneurologic manifestations (summary by Tan et al., 2022).
Restrictive dermopathy 1
MedGen UID:
1812447
Concept ID:
C5676878
Disease or Syndrome
A restrictive dermopathy that has material basis in homozygous or compound heterozygous mutation in the ZMPSTE24 gene on chromosome 1p34.
Ichthyosis, annular epidermolytic, 2
MedGen UID:
1824037
Concept ID:
C5774264
Disease or Syndrome
Annular epidermolytic ichthyosis-2 (AEI2) is characterized by erythema and blistering of skin at birth that improves without scarring, as well as palmoplantar keratoderma. Some patients experience intermittent severe flares of generalized annular and polycyclic erythematous scaling plaques (Sybert et al., 1999; Zaki et al., 2018). For a discussion of genetic heterogeneity of AEI, see AEI1 (607602).
Epidermolytic hyperkeratosis 1
MedGen UID:
1826137
Concept ID:
C5781874
Disease or Syndrome
Epidermolytic hyperkeratosis-1 (EHK1) is a rare autosomal dominant disorder of cornification. The disorder usually presents at birth with erythema and blistering and is characterized in adulthood by warty flexural hyperkeratosis with fewer erosions and blisters. Ultrastructural analysis reveals clumping of the intermediate filaments within keratinocytes of the spinous and granular layers (summary by Whittock et al., 2001). A form of epidermolytic hyperkeratosis that is limited to the palms and soles, designated palmoplantar keratoderma (EPPK; 144200), can also be caused by mutation in KRT1, as well KRT9 (607606). Genetic Heterogeneity of Epidermolytic Hyperkeratosis Mutation in the KRT10 gene (148080) results in both autosomal dominant (EHK2A; 620150) and autosomal recessive (EHK2B; 620707) forms of epidermolytic hyperkeratosis.
RECON progeroid syndrome
MedGen UID:
1841140
Concept ID:
C5830504
Disease or Syndrome
RECON progeroid syndrome (RECON) is a chromosomal instability disorder characterized by postnatal growth retardation, progeroid facial appearance, hypoplastic nose, prominent premaxilla, skin photosensitivity and xeroderma, muscle wasting with reduced subcutaneous fat, and slender elongated thumbs (Abu-Libdeh et al., 2022).

Professional guidelines

PubMed

Zareian MA, Yargholi A, Khalilzadeh S, Shirbeigi L
Dermatol Ther 2019 Nov;32(6):e13102. Epub 2019 Oct 9 doi: 10.1111/dth.13102. PMID: 31583811
Vahlquist A, Fischer J, Törmä H
Am J Clin Dermatol 2018 Feb;19(1):51-66. doi: 10.1007/s40257-017-0313-x. PMID: 28815464Free PMC Article
Wolff H, Fischer TW, Blume-Peytavi U
Dtsch Arztebl Int 2016 May 27;113(21):377-86. doi: 10.3238/arztebl.2016.0377. PMID: 27504707Free PMC Article

Recent clinical studies

Etiology

Pinkova B, Buckova H, Borska R, Fajkusova L
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub 2020 Dec;164(4):357-365. Epub 2020 Oct 21 doi: 10.5507/bp.2020.050. PMID: 33087941
Zareian MA, Yargholi A, Khalilzadeh S, Shirbeigi L
Dermatol Ther 2019 Nov;32(6):e13102. Epub 2019 Oct 9 doi: 10.1111/dth.13102. PMID: 31583811
Vender RB, Andriessen A, Barankin B, Freiman A, Kyritsis D, Mistos LM, Salsberg J, Amar L
J Drugs Dermatol 2019 Jan 1;18(1):80-85. PMID: 30681802
Dizon MV, Galzote C, Estanislao R, Mathew N, Sarkar R
Indian Pediatr 2010 Nov;47(11):959-63. Epub 2010 Mar 15 doi: 10.1007/s13312-010-0161-8. PMID: 20453263
Fleckman P
Skin Therapy Lett 2003 Sep;8(6):3-7. PMID: 14610614

Diagnosis

Souza LS, Lins-Silva DH, Dorea-Bandeira I, Barouh JL, Tolentino A, Bandeira ID, Quarantini LC
Gen Hosp Psychiatry 2021 Nov-Dec;73:54-63. Epub 2021 Sep 1 doi: 10.1016/j.genhosppsych.2021.08.012. PMID: 34600354
Putra PB, Radiono S, Danarti R
Dermatol Online J 2021 Feb 15;27(2) PMID: 33818988
Pinkova B, Buckova H, Borska R, Fajkusova L
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub 2020 Dec;164(4):357-365. Epub 2020 Oct 21 doi: 10.5507/bp.2020.050. PMID: 33087941
Ochando-Ibernon G, Agudo-Mena JL, Martínez-Martínez ML, Rodríguez-Vázquez M, Azaña-Defez JM
Pediatr Dermatol 2020 May;37(3):561-562. doi: 10.1111/pde.14149. PMID: 32598541
Ljosaa TM, Bondevik H, Halvorsen JA, Carr E, Wahl AK
Scand J Pain 2020 Jul 28;20(3):491-498. doi: 10.1515/sjpain-2019-0158. PMID: 32101532

Therapy

Souza LS, Lins-Silva DH, Dorea-Bandeira I, Barouh JL, Tolentino A, Bandeira ID, Quarantini LC
Gen Hosp Psychiatry 2021 Nov-Dec;73:54-63. Epub 2021 Sep 1 doi: 10.1016/j.genhosppsych.2021.08.012. PMID: 34600354
Zareian MA, Yargholi A, Khalilzadeh S, Shirbeigi L
Dermatol Ther 2019 Nov;32(6):e13102. Epub 2019 Oct 9 doi: 10.1111/dth.13102. PMID: 31583811
Vender RB, Andriessen A, Barankin B, Freiman A, Kyritsis D, Mistos LM, Salsberg J, Amar L
J Drugs Dermatol 2019 Jan 1;18(1):80-85. PMID: 30681802
Fleck CA
Ostomy Wound Manage 2006 Apr;52(4):82-6, 88, 90, passim. PMID: 16636365
Fleckman P
Skin Therapy Lett 2003 Sep;8(6):3-7. PMID: 14610614

Prognosis

Delić D, Wolk K, Schmid R, Gabrielyan O, Christou D, Rieber K, Rolser M, Jakob I, Wiech F, Griesser M, Wohnhaas C, Kokolakis G, Witte-Händel E, Baum P, Sabat R
J Dermatol Sci 2020 Jan;97(1):9-20. Epub 2019 Nov 30 doi: 10.1016/j.jdermsci.2019.11.003. PMID: 31843230
Roy AK, Al Basir F, Roy PK
J Theor Biol 2019 Aug 7;474:63-77. Epub 2019 Apr 11 doi: 10.1016/j.jtbi.2019.04.007. PMID: 30980871
Victoire A, Magin P, Coughlan J, van Driel ML
Cochrane Database Syst Rev 2019 Mar 4;3(3):CD011380. doi: 10.1002/14651858.CD011380.pub2. PMID: 30828791Free PMC Article
Itin PH, Moschopulos M, Richard G
Am J Med Genet A 2003 Jul 15;120A(2):237-40. doi: 10.1002/ajmg.a.20036. PMID: 12833406
Guralnik JM, Harris TB, White LR, Cornoni-Huntley JC
J Am Geriatr Soc 1988 Sep;36(9):807-12. doi: 10.1111/j.1532-5415.1988.tb04264.x. PMID: 3411064

Clinical prediction guides

Rao A, Moussa AA, Erickson J, Briskey D
Skin Pharmacol Physiol 2023;36(6):288-295. Epub 2024 Feb 26 doi: 10.1159/000536670. PMID: 38408443Free PMC Article
Putra PB, Radiono S, Danarti R
Dermatol Online J 2021 Feb 15;27(2) PMID: 33818988
Delić D, Wolk K, Schmid R, Gabrielyan O, Christou D, Rieber K, Rolser M, Jakob I, Wiech F, Griesser M, Wohnhaas C, Kokolakis G, Witte-Händel E, Baum P, Sabat R
J Dermatol Sci 2020 Jan;97(1):9-20. Epub 2019 Nov 30 doi: 10.1016/j.jdermsci.2019.11.003. PMID: 31843230
Roy AK, Al Basir F, Roy PK
J Theor Biol 2019 Aug 7;474:63-77. Epub 2019 Apr 11 doi: 10.1016/j.jtbi.2019.04.007. PMID: 30980871
Victoire A, Magin P, Coughlan J, van Driel ML
Cochrane Database Syst Rev 2019 Mar 4;3(3):CD011380. doi: 10.1002/14651858.CD011380.pub2. PMID: 30828791Free PMC Article

Recent systematic reviews

Souza LS, Lins-Silva DH, Dorea-Bandeira I, Barouh JL, Tolentino A, Bandeira ID, Quarantini LC
Gen Hosp Psychiatry 2021 Nov-Dec;73:54-63. Epub 2021 Sep 1 doi: 10.1016/j.genhosppsych.2021.08.012. PMID: 34600354
Victoire A, Magin P, Coughlan J, van Driel ML
Cochrane Database Syst Rev 2019 Mar 4;3(3):CD011380. doi: 10.1002/14651858.CD011380.pub2. PMID: 30828791Free PMC Article

Supplemental Content

Table of contents

    Clinical resources

    Practice guidelines

    • PubMed
      See practice and clinical guidelines in PubMed. The search results may include broader topics and may not capture all published guidelines. See the FAQ for details.
    • Bookshelf
      See practice and clinical guidelines in NCBI Bookshelf. The search results may include broader topics and may not capture all published guidelines. See the FAQ for details.

    Consumer resources

    Recent activity

    Your browsing activity is empty.

    Activity recording is turned off.

    Turn recording back on

    See more...